FIELD: ophthalmology.
SUBSTANCE: group of inventions relates to ophthalmology, namely to treatment of resistant fungal keratitis. Medicinal product for the treatment of resistant fungal keratitis contains bioconjugate of 7% aqueous dispersion of quantum dots of the Ag group 10%: InP/ZnS with a quantum yield of 0.1% and a wavelength of 795 nm and an aqueous solution of an antifungal drug in a ratio of 1:69. A method for the treatment of resistant fungal keratitis, which includes local administration of the above-described medicinal product in an amount of 0.05 ml into the conjunctival cavity of the eye every hour until the inflammatory process is completely suppressed.
EFFECT: above-described product and method are effective for the treatment of resistant fungal keratitis.
5 cl, 3 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF RESISTANT BACTERIAL KERATITIS WITH QUANTUM DOT SOFT CONTACT LENS | 2023 |
|
RU2811935C1 |
| TREATMENT OF RESISTANT ACUTE ENDOPHTHALMITIS WITH QUANTUM DOTS | 2021 |
|
RU2803055C2 |
| METHOD FOR TREATMENT OF FUNGAL ULCER OF CORNEA | 2021 |
|
RU2802388C2 |
| NOVEL DOSAGE FORM FOR TREATING MYCOTIC INFECTION | 2010 |
|
RU2481100C2 |
| METHOD OF TREATING FUNGAL KERATITIS AFTER PENETRATING KERATOPLASTY | 2022 |
|
RU2820070C2 |
| METHOD OF INFECTIOUS KERATITIS TREATMENT | 2007 |
|
RU2352367C1 |
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| METHOD FOR CREATING EXPERIMENTAL MODEL OF FUNGAL KERATITIS AMONG RABBITS | 2020 |
|
RU2746647C1 |
| METHOD FOR TREATMENT OF MYCOTIC CORNEAL ULCERS | 2021 |
|
RU2782494C1 |
| METHOD FOR MODELLING FUNGAL KERATITIS IN RABBITS | 2023 |
|
RU2823978C1 |
